| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |